Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by drjekylon Nov 10, 2016 9:23am
221 Views
Post# 25444047

RE:RE:RE:Rights Offering

RE:RE:RE:Rights Offering beentheredonenothing, find comfort in knowing that, as per the july 2015 video the company is cashflow positive with money having started coming in the door at that time. i wouldn't be worried about money right now and if the cashflow and revenue of the last 16 months isn't enough for you then find solace in the vaccinex license as it appears that the up front payments are more than the cashflow of times gone by and more importantly more than the capital requirements going forward. if that's not enough for you then sell your stock cause these things always take longer than shareholders think. the only thing that matters are licensing transactions unlike the share price of course.

#toindwbmahbn
DRJ!

Bullboard Posts